Announcements Trials

Browse Landscape

Phase

Status

Recruiting 8 Active not recruiting 7 Terminated 6 Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 31 Melanoma 20 Neoplasms 13 Breast Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Prostatic Neoplasms 4 Hodgkin Disease 4 Glioblastoma 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Uterine Cervical Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Adenocarcinoma 3 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms, Squamous Cell 2 Mesothelioma 2

Interventions

Photochemotherapy 2 pembrolizumab 1 peginterferon alfa-2a 1 Tomography, Optical Coherence 1 Therapeutics 1 Surveys and Questionnaires 1 Health 1 Gefitinib 1 Floderm topical cream 1 Early Intervention, Educational 1 Dimethyl Sulfoxide 1 Data Collection 1 Chemexfoliation 1 Cetuximab 1 Biopsy 1 Ascorbic Acid 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Skin Neoplasms × pembrolizumab × Clear all

NCT03666325 2018-09-11

I-Tackle

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡